Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
8.18
-0.10 (-1.21%)
At close: Feb 21, 2025, 4:00 PM
8.33
+0.15 (1.83%)
After-hours: Feb 21, 2025, 6:19 PM EST
CRBP Employees
Corbus Pharmaceuticals Holdings had 19 employees as of December 31, 2023. The number of employees decreased by 14 or -42.42% compared to the previous year.
Employees
19
Change (1Y)
-14
Growth (1Y)
-42.42%
Revenue / Employee
n/a
Profits / Employee
-$2,036,859
Market Cap
99.63M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CRBP News
- 8 days ago - CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025 - GlobeNewsWire
- 11 days ago - Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU - GlobeNewsWire
- 25 days ago - Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 6 weeks ago - Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors - GlobeNewsWire
- 2 months ago - FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer - GlobeNewsWire
- 3 months ago - Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha
- 4 months ago - Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire